GNH USA

Europe — EMA

Nuvaring (Ethinylestradiol, Etonogestrel)

Ethinylestradiol, the active ingredient in Nuvaring, is a combined estrogen-progestogen contraceptive presented as a vaginal ring for intravaginal use. It prevents pregnancy in women of reproductive age.

Request sourcing

1
Pack/s

What is Ethinylestradiol, Etonogestrel?

Ethinylestradiol, the active ingredient in Nuvaring, is a combined estrogen-progestogen contraceptive presented as a vaginal ring for intravaginal use. It prevents pregnancy in women of reproductive age. GNH USA supplies Nuvaring as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Nuvaring as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Ethinylestradiol, Etonogestrel used for?

Nuvaring is a combined hormonal contraceptive that works on the reproductive endocrine pathway to prevent pregnancy.

- Contraception: Provides effective, reversible birth control for women seeking a non‑daily method. - Menstrual cycle regulation: Helps achieve more predictable bleeding patterns. - Acne improvement: May reduce acne severity associated with hormonal fluctuations. - Endometriosis symptom relief: Can lessen pelvic pain linked to endometriial lesions. - Menopausal hormone therapy: Provides estrogen‑progestogen support during perimenopause.

What are the side effects of Ethinylestradiol, Etonogestrel?

This  

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Ethinylestradiol, Etonogestrel
Route
Vaginal Use
Manufacturer
Organon Belgium B.V.
Origin
EU

Related products